Halcion: An Independent Assessment of Safety and Efficacy Data
Regulatory agencies in the United States and United Kingdom, among several other countries, have reviewed extensively the safety and efficacy of Halcion (triazolam) -- a once commonly used hypnotic drug. Concerns about the drugs safety began to emerge when a Dutch physician reported a possible link between Halcion users and a syndrome that included such effects as depression, amnesia, hallucinations, and increased anxiety. In addition, in 1991 Halcion's manufacturer, Upjohn, noted that errors had been identified in a report of one of the clinical studies included in the original application for approval.Since then, the drug has been removed f…
Mehr
CHF 48.90
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V106:
Fremdlagertitel. Lieferzeit unbestimmt
Produktdetails
Weitere Autoren: Division of Health Sciences Policy / Committee on Halcion an Assessment of Da
- ISBN: 978-0-309-05976-3
- EAN: 9780309059763
- Produktnummer: 1741301
- Verlag: Natl Academy Pr
- Sprache: Englisch
- Erscheinungsjahr: 1998
- Seitenangabe: 176 S.
- Masse: H28.7 cm x B20.6 cm x D1.1 cm 503 g
- Gewicht: 503
100 weitere Werke von Institute of Medicine:
Bewertungen
Anmelden